中基健康(000972) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 was 0.00, a decrease of 100.00% compared to 2,758,230.08 in the same period last year[8] - The net profit attributable to shareholders was -19,979,751.27, representing an increase in loss of 53.21% from -13,041,004.34 year-on-year[8] - The net cash flow from operating activities was -25,390,802.51, which is a significant decline of 430.00% compared to -4,790,684.39 in the previous year[8] - The basic earnings per share were -0.0259, a decrease of 53.25% from -0.0169 in the same period last year[8] - The total profit loss increased by 53.13% to ¥-19,988,180.25 compared to ¥-13,053,465.20 in the previous year, indicating ongoing financial challenges[15] - The total comprehensive loss for Q1 2021 was CNY 19,988,180.25, compared to a loss of CNY 13,053,465.20 in the same period last year, marking an increase in losses of approximately 53.5%[40] Assets and Liabilities - The total assets at the end of the reporting period were 562,832,228.58, down 3.38% from 582,505,841.85 at the end of the previous year[8] - The net assets attributable to shareholders decreased by 11.35% to 156,064,088.19 from 176,043,839.46 at the end of the previous year[8] - Total liabilities increased slightly from CNY 401,294,652.22 to CNY 401,609,219.20, reflecting a growth of about 0.8%[31] - The company's total equity decreased from CNY 181,211,189.63 to CNY 161,223,009.38, representing a decline of approximately 11%[32] Cash Flow - The company's cash and cash equivalents decreased by 71.32% to ¥10,613,891.89 from ¥37,007,442.78 due to a transformation and production halt[15] - Cash inflows from operating activities totaled CNY 149,553.82, a significant decrease from CNY 733,296.72 in the previous year[45] - The net cash flow from investing activities was -732,049.14 CNY, with no cash inflow recorded from investment activities[46] - The net cash flow from financing activities was -344,999.99 CNY, compared to -48,005,077.36 CNY in the previous period, showing a reduction in cash outflow related to financing[47] - The ending balance of cash and cash equivalents was 10,548,551.53 CNY, down from 26,161,078.33 CNY in the previous period, indicating a decrease in liquidity[47] Operational Challenges - Operating revenue dropped to ¥0.00, a 100% decrease compared to ¥2,758,230.08 in the previous year, as the company is in a transformation and production halt[15] - Management expenses increased by 63.99% to ¥18,666,259.97, primarily due to fixed asset depreciation[15] - The company reported no non-recurring gains or losses during the reporting period[8] - The company incurred a credit impairment loss of CNY 25,000.00, compared to no losses in the previous year[39] - The company has been actively communicating with investors, responding to over 50 inquiries regarding production and operational status during the reporting period[25] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 33,156[10] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., holds 16.18% of the shares[10] Miscellaneous - The company has not engaged in any securities or derivative investments during the reporting period[20][21] - The company did not report any cash inflow from investment activities, indicating a lack of new investments during the period[48] - The company has not undergone an audit for the first quarter report, which may affect the reliability of the financial data presented[51]